BinaryLogic
$VNRX [Again] Here is the Bull thesis for VNRX, and the strategy that I have purported now for months. The underlying IP is worth at least $150-250M (IMO); however, it has been heavily discounted due to strained liquidity position, warrant/equity conversions and lack of revenue/organic growth. That said-the Company is on the precipice of obtaining a $5M milestone payment (publication pending) on feline lymphoma data, transitioning NuQ NETS assay to IVDR (sepsis) following DETECSEPS, obtaining possible reimbursement in France on Nu.Q NETS lung cancer, and securing multiple possible licensing deals (Sysmex is the most notable near term) across sepsis, cancer, inflammation and other indications. $5.0-6.0M market cap and dilution to continue near term from warrant conversions until one/multiple catalysts noted provide sufficient liquidity to clear debt and re-fortify balance sheet. Watch $0.15-0.30, as I have stated consistently. Multiplier upside possible intermediate term (IMO)
10
